The US Food and Drug Administration (FDA) has approved the first generic version of enoxaparin sodium injection, an anticoagulant used to prevent potentially fatal deep vein thrombosis.
Injectable enoxaparin often is used to prevent blood clots in patients who have had knee or hip replacement or, in some cases, abdominal surgery. Enoxaparin is in the low-molecular-weight heparin class of drugs and is used differently than heparin even though both are anticoagulants.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 2
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.